Free tool
Drug Trial Radar: Respiratory
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
6
Active, not recruiting, industry sponsors, Respiratory, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed277
6 trials
Showing 1 to 6, recently updated first.
- REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive StudyActive, not recruiting
GlaxoSmithKlineGSK (GSK)
NCT06041386 · 177 participants · Start Mar 20, 2024 · Primary completion Feb 12, 2026
Drug: Mepolizumab · For: Asthma
Sites: La Jolla, California; Newport Beach, California; Aurora, Colorado · 65 sites in all
- Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled AsthmaPivotal-lookingActive, not recruiting
GlaxoSmithKlineGSK (GSK)
NCT06372496 · 1,358 participants · Start Apr 16, 2024 · Primary completion Jul 28, 2025
Drug: Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate; Inhaled corticosteroids/long-acting beta-2 agonists · For: Asthma
Sites: Centreville, Alabama; Little Rock, Arkansas; Newport Beach, California · 117 sites in all
- Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine CareActive, not recruiting
AstraZenecaAstraZeneca (AZN)
NCT06422689 · 1,511 participants · Start May 10, 2024 · Primary completion Feb 3, 2027
Drug: Albuterol and budesonide inhalation aerosol · For: Asthma
Sites: North Hollywood, California; Walnut Creek, California; Louisville, Kentucky · 11 sites in all
- Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled AsthmaPivotal-lookingActive, not recruiting
Regeneron PharmaceuticalsRegeneron (REGN)
NCT06572228 · 120 participants · Start Aug 26, 2024 · Primary completion Apr 24, 2027
Drug: dupilumab; Matching Placebo and 1 more · For: Asthma
Sites: Bakersfield, California; La Jolla, California; Lancaster, California · 77 sites in all
- Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe AsthmaPivotal-lookingActive, not recruiting
SanofiSanofi (SNY)
NCT05097287 · 1,339 participants · Start Dec 16, 2021 · Primary completion Mar 16, 2027
Drug: Dupilumab; Placebo · For: Asthma
Sites: Cullman, Alabama; Sheffield, Alabama; Chandler, Arizona · 249 sites in all
- A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial HypertensionActive, not recruiting
United TherapeuticsIndustry
NCT05203510 · 52 participants · Start Oct 20, 2022 · Primary completion Apr 30, 2026
Drug: Parenteral Treprostinil; Oral Treprostinil · For: Pulmonary Arterial Hypertension
Sites: Phoenix, Arizona; Fresno, California; Los Angeles, California · 28 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.